IFN-ELP fusion protein (Tsinghua University)

N/A

Report date: 2025/03/20 14:49:56

Base Information

Drug NameIFN-ELP fusion protein (Tsinghua University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterferon alpha 2 ligandElastin stimulants
TargetsInterferon alpha-2Elastin
Therapy Area/IndicationsMultiple SclerosisHepatitisArthritis, Rheumatoid +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTsinghua University
China Registration ClassN/A

Develop Information

Active CompaniesTsinghua University
Inactive CompaniesN/A
Active IndicationsMultiple SclerosisHepatitisArthritis, Rheumatoid +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A